Douglas Lane & Associates’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,000
| Closed | -$17K | – | 249 |
|
|
2023
Q4 | $17K | Hold |
10,000
| – | – | ﹤0.01% | 243 |
|
|
2023
Q3 | $10.3K | Hold |
10,000
| – | – | ﹤0.01% | 233 |
|
|
2023
Q2 | $11.6K | Hold |
10,000
| – | – | ﹤0.01% | 234 |
|
|
2023
Q1 | $15.1K | Hold |
10,000
| – | – | ﹤0.01% | 226 |
|
|
2022
Q4 | $25K | Buy |
+10,000
| New | +$25K | ﹤0.01% | 225 |
|